TransCode Therapeutics Inc (NASDAQ: RNAZ) is -85.46% lower on its value in year-to-date trading and has touched a low of $0.52 and a high of $66.33 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RNAZ stock was last observed hovering at around $0.52 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.49, the stock is -53.64% and -89.93% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 22.79 million and changing -5.77% at the moment leaves the stock -96.10% off its SMA200. RNAZ registered -97.75% loss for a year compared to 6-month loss of -97.71%. The firm has a 50-day simple moving average (SMA 50) of $4.86712 and a 200-day simple moving average (SMA200) of $12.557165.
The stock witnessed a -80.56% gain in the last 1 month and extending the period to 3 months gives it a -86.08%, and is -56.25% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 18.66% over the week and 23.16% over the month.
TransCode Therapeutics Inc (RNAZ) has around 10 employees, a market worth around $11.44M and $0.00M in sales. Distance from 52-week low is -5.08% and -99.26% from its 52-week high. The company has generated returns on investments over the last 12 months (-903.45%).
with sales reaching $300k over the same period.The EPS is expected to grow by 95.41% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
TransCode Therapeutics Inc (RNAZ) Top Institutional Holders
11.0 institutions hold shares in TransCode Therapeutics Inc (RNAZ), with institutional investors hold 0.67% of the company’s shares. Institutions hold 0.67% of the Float.
TransCode Therapeutics Inc (RNAZ) Insider Activity
#####
